David R. Guyer, Director at EyePoint Pharmaceuticals, Inc. (EYPT), sold 23,250 shares at $10.30 ($239K) on 2024-06-03, disclosed to the SEC on 2024-06-04.
Scheduled sale ($239k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.30 | 11,625 | $120K | 50.0% |
| 2 | $10.30 | 11,625 | $120K | 50.0% |
| Total | $10.30 avg | 23,250 | $239K | 100% |
| Filing → |
| ISEE | SELL | 2020-12-15 | $133K | — | Filing → |
| ISEE | SELL | 2020-12-11 | $134K | — | Filing → |
| ISEE | SELL | 2020-01-07 | $27K | — | Filing → |